Estonia vs Lao People's Democratic Republic: Access to anti-retroviral drugs, female
Estonia
70.0%
in 2022
Lao People's Democratic Republic
71.0%
in 2024
Estonia rank
82nd
Lao People's Democratic Republic rank
81st
Access to anti-retroviral drugs, female over time
- Estonia
- Lao People's Democratic Republic
How they compare
Lao People's Democratic Republic currently reports 71.0% against 70.0% in Estonia, a difference of 1.0%.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Estonia ahead.
Estonia ranks 82nd and Lao People's Democratic Republic ranks 81st of 141 countries.
Estonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Estonia | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.7% | 7.7% | 4.0% | Estonia |
| 2010s | 57.8% | 35.9% | 21.9% | Estonia |
| 2020s | 71.7% | 56.7% | 15.0% | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Estonia or Lao People's Democratic Republic?
- Lao People's Democratic Republic, at 71.0% against 70.0% in Estonia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Estonia and Lao People's Democratic Republic?
- 1.0%, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Estonia and Lao People's Democratic Republic?
- 22 years are reported by both, from 2000 to 2022.
- How do Estonia and Lao People's Democratic Republic rank globally for access to anti-retroviral drugs, female?
- Estonia ranks 82nd and Lao People's Democratic Republic ranks 81st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.